News from elysium health A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 21, 2019, 09:00 ET Elysium Health™ Announces Clinical Trial to Explore the Effect of Basis™ on Liver Fat Accumulation in Healthy Adults with Fatty Liver (NAFL)

Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on advancements in scientific research, today...


Nov 04, 2019, 07:00 ET Elysium Health™ Announces Head of Bioinformatics and the Launch of INDEX by Elysium Health

Elysium Health, Inc.,TM a life sciences company developing clinically validated health products based on aging research, today announced the launch...


Oct 30, 2019, 12:23 ET Standard International and Elysium Health™ Announce Science-Backed Wellness Partnership

Elysium Health, Inc.™, a life sciences company developing clinically validated health products based on aging research, and Standard International,...


Sep 19, 2019, 11:00 ET Elysium Health™ Announces FDA Acceptance of Investigational New Drug Application to Evaluate BASIS™ for Prevention of Acute Kidney Injury in Surgical Cardiac Patients

Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on aging research, today announced the...


Aug 09, 2019, 11:30 ET Elysium Health™ Announces Initiation of Clinical Trial to Explore the Effects of Basis™ and High-Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance

Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on aging research, today announced the...


Sep 19, 2018, 10:00 ET Elysium Health™ Responds to Baseless Allegations by Disgruntled Former Supplier

Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on aging research, responded today to the...


Aug 16, 2018, 10:00 ET Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on aging research, has entered into an exclusive ...


Aug 14, 2018, 10:00 ET Elysium Health™ Announces Its Cellular Health Product Basis is NSF Certified for Sport

Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on aging research, today announced that its...


Mar 29, 2018, 09:15 ET Elysium Health™ Granted Orphan Drug Designation for EH301 to Treat Amyotrophic Lateral Sclerosis (ALS)

Elysium Health, Inc.,™ today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug ...


Feb 21, 2018, 08:37 ET Elysium Health™ Welcomes Two New Board Members

Elysium Health, Inc.,TM a consumer health company developing scientifically sound health products, today announced the addition of two new board...


Nov 27, 2017, 07:00 ET Elysium Health™ Announces Positive Data on Its Product BASIS Published in "Nature Partner Journals: Aging and Mechanisms of Disease"

Elysium Health, Inc.,™ a consumer health company developing scientifically-sound natural health products, today announced that detailed results from...


Oct 04, 2017, 08:30 ET Elysium Health™ Launches Elysium Scholars, an Annual Scholarship Program that Supports New York City High School Seniors Pursuing an Education in the Sciences

Elysium Health, Inc.,™ a consumer health company developing scientifically-sound natural health products, today announced that it will launch Elysium ...


Jun 29, 2017, 08:30 ET Elysium Health™ Secures $5 Million Credit Facility From Silicon Valley Bank

Elysium Health, Inc.,™ a consumer health company developing scientifically-sound dietary supplements, today announced that it secured a $5 million...


Mar 13, 2017, 08:30 ET Elysium Health ™ Enters Multi-Year Research Agreement with Harvard University

Elysium Health, Inc.,TM a consumer health company whose mission is to develop evidence-based dietary supplements, today announced a multi-year...


Dec 06, 2016, 03:00 ET Elysium Health™ Raises $20 Million In Series B Financing Led By General Catalyst, Announces Topline Clinical Trial Results For Its First Product BASIS™, And Welcomes Leading Scientists And Physicians To Its Scientific Advisory Board

Elysium Health, Inc., ™ a provider of scientifically-sound dietary supplements, today announced it has raised $20 million in Series B financing led...


Feb 03, 2015, 08:00 ET Elysium Health™ Establishes New Category Of Scientifically Validated Dietary Supplements With Release Of BASIS™, An Advanced Daily Supplement Designed To Enhance Metabolic Repair And Optimization

Elysium Health LLC, a provider of a new category of scientifically validated dietary supplements, today announced the release of BASISTM, an advanced ...